Public Employees Retirement System of Ohio reduced its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 22.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,815 shares of the company’s stock after selling 1,087 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Pediatrix Medical Group were worth $55,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of MD. GAMMA Investing LLC grew its stake in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after buying an additional 1,765 shares during the period. Marshall & Sullivan Inc. WA purchased a new stake in Pediatrix Medical Group during the second quarter worth approximately $41,000. AlphaQuest LLC grew its stake in Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock worth $85,000 after buying an additional 811 shares during the period. Squarepoint Ops LLC purchased a new stake in Pediatrix Medical Group during the fourth quarter worth approximately $132,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in Pediatrix Medical Group during the first quarter worth approximately $159,000. 97.71% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages have recently weighed in on MD. Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Zacks Research upgraded shares of Pediatrix Medical Group to a “strong-buy” rating in a research note on Monday, August 11th. UBS Group upped their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Leerink Partners upped their target price on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Pediatrix Medical Group in a research note on Saturday, September 27th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $16.79.
Pediatrix Medical Group Stock Up 0.0%
Shares of NYSE:MD opened at $17.65 on Wednesday. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of 13.68 and a beta of 1.26. Pediatrix Medical Group, Inc. has a 1-year low of $11.59 and a 1-year high of $18.22. The company’s fifty day moving average is $16.02 and its two-hundred day moving average is $14.46. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, topping analysts’ consensus estimates of $0.42 by $0.11. The company had revenue of $468.84 million for the quarter, compared to analysts’ expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm’s revenue was down 7.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.34 earnings per share. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
- Five stocks we like better than Pediatrix Medical Group
- What Investors Need to Know About Upcoming IPOs
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- Why is the Ex-Dividend Date Significant to Investors?
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- What is the Dogs of the Dow Strategy? Overview and Examples
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.